10 Ways the World Got Better In 2022
Over the past year, the headlines have been dominated by alarming events: the Russian invasion of Ukraine, high inflation, supply chain shortages, and the threat of food insecurity for many nations. But 2022 was also a year of milestones toward a better future, scientific breakthroughs, and stories of hope. Here’s a look at 10 stories of human progress from the last 12 months.
1. We found out that civilization reached peak agricultural land
For nearly all of human history, producing more food required more land. But starting in the early 1900s, and continuing through the next 100 years, four powerful forces—syn...
Source: TIME: Health - December 28, 2022 Category: Consumer Health News Authors: Tony Morley Tags: Uncategorized climate change freelance global health Health Care healthscienceclimate Londontime Source Type: news
Keep The Flu Away In A Time Of “ Twindemics ”
Flu season is here, and the CDC has shifted into overdrive…pushing you to get your flu vaccine as soon as possible.
Once again, they’re insisting it’s more important than ever because of Covid.
Flu shots have an unquestioned reputation. The message from the medical establishment is that you need to ignore any vaccines’ potential adverse effects.
But that doesn’t mean they don’t exist…
In a moment, I’ll show you ways to bolster your native immunity so you can enjoy optimal health year-round. But first, for my new readers, let me tell you why I’ll never get a flu shot.
Unlike some of my colleagues i...
Source: Al Sears, MD Natural Remedies - December 23, 2022 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Health Source Type: news
Monkeypox as an emerging infectious disease: the ophthalmic implications
The 2022 outbreak of monkeypox is of worldwide significance. There has been a rapid escalation in case numbers despite efforts to contain it and the WHO has declared it a Public Health Emergency of International Concern. To date, over 51 257 laboratory-confirmed cases have been reported, the majority in non-endemic countries, with 3279 in the UK. It is vital for ophthalmologists to understand this disease and the risk it poses. Human monkeypox is a zoonotic disease caused by the monkeypox virus, a double-stranded DNA virus in the Orthopoxvirus genus of the Poxviridae family. Other orthopoxviruses include variola (smallpox)...
Source: Current Awareness Service for Health (CASH) - December 21, 2022 Category: Consumer Health News Source Type: news
News at a glance: Logging ’s effects, endangered abalone, and a contract for UC postdocs
CONSERVATION
Life can thrive in a partially logged forest, study finds
Forest
plants and animals can thrive in selectively logged areas
, calling into question their designation as degraded ecosystems, a study in Malaysia has found. An international team of researchers studied differences among an intact old forest, partly logged forest areas, and sites cleared for oil palm plantations, all of them in Sabah state on northern Borneo. The scientists used data—gathered over 12 years by the Stability of Altered Forest Ecosystems project, one of the world’s largest ecological studies—abou...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news
Science ’s 2022 Breakthrough of the Year: A telescope’s golden eye sees the universe anew
html { scroll-behavior: smooth; } .news-article-content--featured>.bodySection>.mb-2x:not(:first-of-type) { display: none; } h3 { scroll-margin-top: 5rem; } .parent-section h3, .subsection h3 { font-size: 1.375rem; line-height: 1.875rem; } .news-article-content-footer h2 { display: none; } .toc img { padding-bottom: 16px; transition: opacity .25s; } .toc img:hover { opacity: 60%; } .toc .image-grid img { padding-bottom: 16px; padding-top: 16px; } .image-grid .news-article__figure__image__wrapper:before, .image-grid .news-article__figure__image__wrapper:after { display: none; } .news-article...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news
TIME ’ s Best Photojournalism of 2022
We’ve entered a strange moment in history where every year feels somehow both a burning furnace of upheaval and recreation and a frozen monolith we are made to unwillingly re-encounter over and over. The images captured by TIME’s global roster of photojournalists over the course of 2022 reveal how deeply these two opposing trends penetrated society and public discourse this past year.
Photos showing the grief of the Uvalde, Texas community over the horror that occurred at a local elementary school on May 24, in which an 18-year-old man fatally shot 19 students and two teachers, highlight how gun violence and ma...
Source: TIME: Health - December 13, 2022 Category: Consumer Health News Authors: TIME Photo Department Tags: Uncategorized climate change Climate Is Everything COVID-19 Evergreen feature Health Care LGBTQ Photo Technology Source Type: news
Real-World Study Shows Patients Treated with IMBRUVICA ® (ibrutinib) Were Less Likely to Initiate a Next-Line Treatment than Patients on Acalabrutinib in First-line Chronic Lymphocytic Leukemia
NEW ORLEANS, December 12, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a real-world study showing that patients with chronic lymphocytic leukemia (CLL) treated with first-line acalabrutinib monotherapy were 89 percent more likely to start a next-line treatment than those treated with IMBRUVICA® (ibrutinib).[1] These data suggest the potential that first-line treatment with IMBRUVICA® in routine practice may provide patients with the ability to use once-daily, all-oral IMBRUVICA® as a monotherapy treatment for a longer period without the need to start the next line of ...
Source: Johnson and Johnson - December 12, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
New Results from the Phase 3 GLOW Study of Fixed-Duration Treatment with IMBRUVICA ® (ibrutinib) Plus Venetoclax Demonstrate Robust Efficacy and Sustained Response in Older, Unfit Patients with Previously Untreated Chronic Lymphocytic Leukemia
NEW ORLEANS, December 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new four-year follow-up results from the Phase 3 GLOW study (Abstract #93), which showed investigational, fixed-duration treatment with IMBRUVICA® + venetoclax (I+V) reduced the risk of progression or death by 79 percent among older and/or unfit patients with previously untreated chronic lymphocytic leukemia (CLL) compared to patients treated with chemoimmunotherapy.[i] These results were highlighted in an oral presentation during the 2022 American Society of Hematology (ASH) Annual Meeting.1CLL is the most com...
Source: Johnson and Johnson - December 10, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
News at a glance: Snags in emissions monitoring, negotiations on biodiversity, and a drug for sleeping sickness
CLIMATE SCIENCE
Volcano and NASA deliver blows to climate monitoring
Efforts to monitor global greenhouse gas emissions suffered two setbacks last week—one by chance, one by choice. In Hawaii, the first eruption of the Mauna Loa volcano since 1984 has cut off road access and power to a famed summit lab that has monitored atmospheric carbon dioxide (CO
2
) levels since 1958. Although lava flows have so far spared the lab, which is run by the National Oceanic and Atmospheric Administration (NOAA), measurements are unlikely to resume for several months. That means tracking data will have to...
Source: ScienceNOW - December 8, 2022 Category: Science Source Type: news
What China ’s Zero-COVID Policy Means for the Pandemic—in China and the Rest of the World
Protests in multiple Chinese cities over the strict COVID-19 policies enforced by China’s government reflect the growing sentiment of people around the world. We’re tired of the pandemic, and tired of the myriad ways the SARS-CoV-2 virus has changed our lives forever. But the demonstrations in China also reflect a more specific, local frustration with a strategy for controlling the virus that every other country in the world has long since left behind.
China’s zero-COVID strategy is an extension of the drastic measures instituted, not only in that country but in others around the world, including the U.S....
Source: TIME: Health - December 2, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Dog Flu Is Back, Too
Canine influenza can spread quickly through shelters, kennels and day care facilities, although most dogs will recover on their own, experts said. (Source: NYT Health)
Source: NYT Health - December 2, 2022 Category: Consumer Health News Authors: Emily Anthes Tags: Dogs Animals Pets Veterinary Medicine Animal Behavior Vaccination and Immunization Viruses Influenza Humane Society of the United States Charlotte (NC) Alabama Chicago (Ill) your-feed-science your-feed-animals Source Type: news
One Step Closer to a Universal Flu Vaccine?
Scientist have tested in animals a vaccine that may protect against 20 strains of influenza, helping to prevent another pandemic. (Source: NYT Health)
Source: NYT Health - November 29, 2022 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Vaccination and Immunization Research Coronavirus (2019-nCoV) Influenza Children and Childhood Viruses Epidemics Science (Journal) Source Type: news
WHO Renames Monkeypox as mpox, Citing Racism Concerns
LONDON — The World Health Organization has renamed monkeypox as mpox, citing concerns the original name of the decades-old animal disease could be construed as discriminatory and racist.
The U.N. health agency said in a statement Monday that mpox was its new preferred name for monkeypox, saying that both monkeypox and mpox would be used for the next year while the old name is phased out.
WHO said it was concerned by the “racist and stigmatizing language” that arose after monkeypox spread to more than 100 countries. It said numerous individuals and countries asked the organization “to propose a way f...
Source: TIME: Health - November 28, 2022 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized healthscienceclimate monkeypox wire Source Type: news
Successful tests in animal models pave way for strategy for universal flu vaccine
An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, according to a study. This could serve one day as a general preventative measure against future flu pandemics, the researchers from University of Pennsylvania, US, said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2022 Category: Pharmaceuticals Source Type: news
Universal flu vaccine could counter future pandemic
Animal trials, using the same mRNA technology as successful Covid vaccines, have gone well, scientists say. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 25, 2022 Category: Consumer Health News Source Type: news
